#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Amber Weissenfluh Email
Director, Pharmaceutical Development . Viking Therapeutics
San Diego, CA
Locationa***********@vikingtherapeutics.com
Primary EmailHow to contact Amber Weissenfluh
Join and see Amber's contact info for free!Current Roles
Employees:
31Revenue:
$6.2MAbout
Viking Therapeutics, Inc. (Nasdaq:VKTX) is a clinical-stage company focused on the development of first-in-class or best-in-class therapies for metabolic and endocrine disorders. Our most advanced candidate is a non-steroidal selective androgen receptor modulator (SARM) currently in Phase 2 trial for the treatment recovery from hip fracture surgery. Our thyroid receptor beta (TRb) agonist platform, also in Phase 2, is being developed for lipid disorders such as hypercholesterolemia and fatty liver diseases such as non-alcoholic steatohepatitis (NASH) as well as for rare diseases of glycogen storage disease (GSD 1a) and X-linked adrenoleukodystrophy, or X-ALD. See more at http://www.vikingtherapeutics.comViking Therapeutics Address
12340 El Camino RealSan Diego, CA
United States